Innovative Approaches to Drug Development in CNS Research
CNS drug development is entering a new era, fueled by advances in artificial intelligence, biomarker science, digital health technologies, and precision medicine. This workshop will explore how innovative approaches are transforming the development of therapies for neurodegenerative and neurological disorders by accelerating target identification, optimizing clinical trial design, improving patient selection, and enhancing the prediction of treatment response.
Through expert presentations, participants will gain insights into the evolving role of biological, digital, imaging, and wearable biomarkers in advancing more efficient, data-driven drug development strategies. The session will highlight real-world applications, emerging technologies, and opportunities to bring more targeted, personalized, and potentially disease-modifying therapies to patients.
Designed for clinicians, researchers, and industry professionals, this workshop will provide a practical perspective on the innovations shaping the future of CNS research and the next generation of therapeutic development.
Event Details: Free Half-day Workshop
Date: 26 October 2026
Location: The Samuel Hotel, Spencer Place, North Wall Quay, Dublin, D01 R9N4 | Beckett Suite
Format: Educational Workshop from 8:30 to 14:00 CET, followed by Lunch Networking Session
Agenda
08:30 – 08:50 | Welcome & Breakfast
08:50 – 09:00 | Introduction
09:00 – 09:30 | Gary Zammit, PhD | Founder and Executive Chairperson | Clinilabs
09:30 – 10:00 | Professor John Harrison, PhD | Associate Professor | Alzheimer Center Amsterdam
10:00 – 10:30 | Lynne Hughes, BMed Sci, PhD, PMP | Chief of Staff | GAP Foundation
10:30 – 10:45 | Coffee Break
10:45 – 11:15 | Chris Lynch, Acting CEO & Director of Policy, Research, Communication & Publications | Alzheimer’s Disease International
11:15 – 11:55 | Andreas Borta, PhD | Chief Medical Officer | Teitur Trophics
11:55 – 12:25 | Tim Williams, PhD | Chief Medical Officer | Amandala Neuro
12:25 – 12:35 | Closing Remarks
- Key Takeaways
12:35 – 13:35 | Networking Lunch
